Autism Spectrum Disorder Trial, Recruiting (NCT05551728)

Autism Spectrum Disorder Trial, Recruiting NCT05551728 Sponsor: Duke University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT05551728 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child is between 18 and 72 months old (1.5 to 6 years old)
The child has been diagnosed with autism spectrum disorder (ASD) based on standard diagnostic criteria and assessment tools
The child's caregiver speaks isiXhosa, isiZulu, Afrikaans, or English
The child is of African or Coloured (a South African term for mixed race) background
The caregiver and child live in the area where the trial is recruiting participants
The caregiver is 18 years old or older

Who may not be able to join:

The child has a known genetic condition, such as fragile X syndrome
The child has significant difficulties with their senses or movement that would prevent them from using the play materials involved in the study
The child has major physical differences that would make it difficult to take part in the activities
The child has a history of a serious head injury or a neurological (brain or nervous system) condition
The caregiver does not feel they will be able to attend the assessments and 12 sessions required by the trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1919 681-0023

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05551728

Sponsor: Duke University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +1919 681-0023

More information: https://clinicaltrials.gov/study/NCT05551728

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child is between 18 and 72 months old (1.5 to 6 years old)
The child has been diagnosed with autism spectrum disorder (ASD) based on standard diagnostic criteria and assessment tools
The child's caregiver speaks isiXhosa, isiZulu, Afrikaans, or English
The child is of African or Coloured (a South African term for mixed race) background
The caregiver and child live in the area where the trial is recruiting participants
The caregiver is 18 years old or older

Who may not be able to join:

The child has a known genetic condition, such as fragile X syndrome
The child has significant difficulties with their senses or movement that would prevent them from using the play materials involved in the study
The child has major physical differences that would make it difficult to take part in the activities
The child has a history of a serious head injury or a neurological (brain or nervous system) condition
The caregiver does not feel they will be able to attend the assessments and 12 sessions required by the trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Duke University

Registry

ClinicalTrials.gov

Start date

1 April 2023

Est. completion

1 March 2027

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

Change from Baseline VABS-3 Communication Domain Standard Score at 6 months; Change from Baseline Griffiths III Language and Communication Developmental Quotient at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov